Other genes in which mutations have been reported to be associated with PPCM onset and progression include truncations in DMD (dystrophin that causes Duchenne’s Muscular Dystrophy) (Cheng and Prior, 2013; Ahmed et al., 2016), DSP (desmoplakin) (Ware et al., 2016), TPM1 (α-tropomyosin)(Ware et al., 2016), and missense mutations in MYBPC3 (cardiac myosin binding protein C) (Morales et al., 2010), TNNC1 (cardiac troponin C) (Mestroni et al., 1994), TNNT2 (cardiac troponin T) (Morales et al., 2010), and LAMP2 (lysosome-associated membrane protein) (Ware et al., 2016). The gene discussed is DSP; the disease is Duchenne muscular dystrophy.